American International Group, Inc. Clene Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $21,369 - $41,925	-10,176 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.42 - $4.42 $1,730 - $3,160	-715 Reduced 6.57%	10,176 $40,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $7.53 $616 - $1,174	156 Added 1.45%	10,891 $45,000
Q3 2021 Nov 12, 2021	SELL	$6.83 - $13.58 $14,247 - $28,327	-2,086 Reduced 16.27%	10,735 $73,000
Q2 2021 Aug 13, 2021	BUY	$6.98 - $13.33 $89,490 - $170,903	12,821 New	12,821 $144,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.